Advances in the treatment and prognosis of aggressive NK-cell leukemia: results from the ANKL22 study. Fujimoto A, Maeda T, Doki N, Fukuhara N, et al. Leukemia 2026 Jan 7. doi: 10.1038/s41375-025-02854.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fujimoto A, Maeda T, Doki N, Fukuhara N, et al. Advances in the treatment and prognosis of aggressive NK-cell leukemia: results from the ANKL22 study. Leukemia 2026 Jan 7. doi: 10.1038/s41375-025-02854.
PMID: 41501503